The role of adhesion molecules and T cells in ischemic renal injury

Current Opinion in Nephrology and Hypertension

Volumn 12, Issue 1, 2003, Pages 85-90

  Burne Taney, Melissa J ^a   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Kidney injury; T cells

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; L SELECTIN;

ACUTE KIDNEY FAILURE; HUMAN; KIDNEY INJURY; KIDNEY ISCHEMIA; LEUKOCYTE ADHERENCE; LYMPHOCYTE FUNCTION; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; RENAL CIRCULATION; REPERFUSION INJURY; T-LYMPHOCYTES;

EID: 0037228767     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200301000-00014     Document Type: Review

References (48)

1. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64:945-947.
2. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54:1817-1831.
3. Rabb H, Bonventre J. Experimental strategies for ATN - the future. In: Therapy in nephrology and hypertension: a companion to Brenner and Rector's 'The kidney'. Brady HR, Wilcox C (editors). Philadelphia: WB Saunders Company; 1998.
4. Rabb H, Star R. Inflammatory response and its consequences in acute renal failure. In: Acure renal failure: a companion to Brenner and Rector's 'The kidney'. Molitoris BA, Finn WF (editors). Philadelphia: WB Saunders Company; 2001. pp. 89-100. This is a detailed review of the inflammatory response in ARF and its implications in the clinical setting.
5. Barinaga M. Finding new drugs to treat stroke. Science 1996; 272:664-666.
6. Solez K, Morel-Maroger L, Sraer JD. The morphology of 'acute tubular necrosis' in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 1979; 58:362-376.
7. Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int 1974; 6:24-37.
8. Koo DD, Welsh KI, McLaren AJ, et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int 1999; 56:1551-1559.
9. Klausner JM, Paterson IS, Goldman G, et al. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989; 256:F794-F802.
10. Okusa MD, Linden J, Huang L, et al. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 2000; 279:F809-F818.
11. Nemoto T, Burne MJ, Daniels F, et al. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 2001; 60:2205-2214. This paper describes the use of TBC-1269 (a small molecules selectin ligand inhibitor) in a rat model of ischemic ARF. Tissue protection was afforded by selectin ligand blockade despite brisk infiltration of neutrophils into the kidney postischemia.
12. Burne MJ, Daniels F, EI Ghandour A, et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108:1283-1290. This paper demonstrates an important role for CD4 T cells in a mouse model of renal IRI. It begins to elucidate possible mechanisms and identifies that CD28 and IFN-γ pathways are involved.
13. Jo SK, Yun SY, Chang KH, et al. alpha-MSH decreases apoptosis in ischemic acure renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 2001; 16:1583-1591. This paper discusses the role of α-MSH in ARF in rats. α-MSH significantly reduced functional injury and reduced the degree of apoptosis.
14. Chiao H, Kohda Y, McLeroy P, et al. Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 1998; 54:765-774.
15. Okusa MD, Day Y, Linden J, et al. Chimeric wild-type/A2A-adenosine receptor knockout mice demonstrate that inflammatory cells are the target of A2A-agonist mediated protection of ischemia reperfusion injury in mouse kidneys. J Am Soc Nephrol 2001; 12:789A.
16. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15:1562-1574.
17. Rabb H, Mendiola CC, Dietz J, et al. Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol 1994; 267:F1052-F1058.
18. Kelly KJ, Williams WW, Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 1994; 91:812-816.
19. Tajra LC, Martin X, Margonari J, et al. Antibody-induced modulation of the leukocyte CD11b integrin prevents mild but not major renal ischemic injury. Nephrol Dial Transplant 2000; 15:1556-1561.
20. Kelly KJ, Williams WW, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97:1056-1063.
21. Rabb H, Mendiola CC, Saba SR, et al. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995; 211:67-73.
22. Deng J, Kohda Y, Chiao H, et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001; 60:2118-2128. This study demonstrates a role for the cytokine IL-10 in a mouse model of IRI. IL-10 was proposed to act by inhibiting the maladaptive activation of genes that cause leukocyte activation and adhesion, and the induction of inducible nitric oxide synthase.
23. Takahira R, Yonemura K, Fujise Y, Hishida A. Dexamethasone attenuates neutrophil infiltration in the rat kidney in ischemia/reperfusion injury: the possible role of nitroxyl. Free Radic Biol Med 2001; 31:809-815. This paper illustrates that dexamethasone decreases neutrophil infiltration. This effect was dissociated from the effects on renal function postischemia.
24. Burne MJ, Elghandour A, Haq M, et al. IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol 2001; 70:192-198. This study demonstrates that ICAM-1 and vascular cell adhesion molecule type 1 upregulation observed postischemia can occur in the absence of both IL-1 and tumor necrosis factor pathways.
25. Rabb H, Mendiola C, Saba S, et al. Antibodies to P-selectin and ICAM-1 protect kidneys from ischemic reperfusion injury. J Am Soc Nephrol 1994; 5:907A.
26. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 2000; 14:48-54.
27. Singbartl K, Ley K. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 2000; 28:2507-2514.
28. Singbartl K, Forlow SB, Ley K. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 2001; 15:2337-2344. This elegant mechanistic paper defines the important role for platelet P-selectin in renal IRI using a bone marrow transplantation model.
29. Bojakowski K, Abramczyk P, Bojakowska M, et al. Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat. J Physiol Pharmacol 2001; 52:137-143. This study demonstrates a role for fucoidan (a non-selective selectin inhibitor) in rat renal IRI.
30. Burne MJ, Rabb H. Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. J Immunol 2002; 169:2648-2652. This study demonstrates that fucosyltransferase enzymes play an important role in renal IRI by adding key fucosyl groups to selectin ligands.
31. Rabb H. The T cell as a bridge between innate and adaptive immune systems: Implications for the kidney. Kidney Int 2002; 61:1935-1946.
32. Lemay S, Rabb H, Postler G, Singh AK. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 2000; 69:959-963.
33. Zwacka RM, Zhang Y, Halldorson J, et al. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100:279-289.
34. Rabb H, Daniels F, O'Donnell M, et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279:F525-F531.
35. DeGreef KE, Ysebaert DK, Dauwe S, et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60:1415-1427.
36. Park P, Haas M, Cunningham PN, et al. Injury in renal ischemia-reperfusion is independent from immunoglobulins anal T lymphocytes. Am J Physiol Renal Physiol 2002; 282:F352-F357.
37. Yokota N, Rabb H. A complex role for T cells in renal ischemia reperfusion injury. A comparison of four T cell deficient mouse strains. J Am Soc Nephrol 2002; 13:550A.
38. Shultz LD, Lang PA, Christianson SW, et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000; 164:2496-2507.
39. Yokota N, Burne MJ, Rabb H. The identification of protective as well as pathogenic T cell subsets in renal ischemia reperfusion injury. Am J Transplant 2002; 2 (Suppl. 3):224.
40. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995; 269:1727-1730.
41. Song E, Zou H, Yao Y, et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002; 61:676-685. This study demonstrates the importance of RANTES in renal injury, showing that the blockade of chemokine receptors by Met-RANTES diminishes early infiltration and the activation of mononuclear cells in post-transplant grafts.
42. Miura M, Fu X, Zhang QW, et al. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 2001; 159:2137-2145. A study of two important chemokines (Gro-alpha and MIP-2) showing their important role in mediating renal IRI. The results indicate the efficacy of neutralizing the chemokines directing leukocytes into ischemic kidneys during reperfusion to attenuate the resulting tissue damage.
43. Crisman JM, Richards LL, Valach DP, et al. Chemokine expression in the obstructed kidney. Exp Nephrol 2001; 9:241-248.
44. Chaudhri G, Clark IA, Hunt NH, et al. Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol 1986; 137:2646-2652.
45. Chien CT, Lee PH, Chen CF, et al. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 2001; 12:973-982. A novel method of identifying free radical production in the rat kidney postischemia.
46. Molitoris BA, Sandoval R, Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 2002; 30 (Suppl 5):S235-S240. An elegant review outlining the importance of the endothelium in ischemic ARF and advances made in the past few years.
47. Conesa EL, Valero F, Nadal JC, et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 2001; 281:R730-R737.
48. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282:F1140-F1149. A provocative study demonstrating that the implantation of endothelial cells or their surrogates expressing functional endothelial nitric oxide synthase in the renal microvasculature resulted in a dramatic functional protection of ischemic kidneys.